CIK: 0001346824 · Show all filings
Period: Q4 2017 (← Previous) (Next →)
Filing Date: Feb 14, 2018
Total Value ($000): $1,195,149 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES LTD | 7,512,049 | $263,673 | 22.1% | $16.44 | +77.3% | SHS | Y95308105 |
| ASND | ASCENDIS PHARMA A S | 5,580,690 | $223,562 | 18.7% | $17.96 | — | SPONSORED ADR | 04351P101 |
| — | AVEXIS INC | 1,171,278 | $129,625 | 10.8% | $31.86 | — | COM | 05366U100 |
| — | SAGE THERAPEUTICS INC | 455,173 | $74,972 | 6.3% | $164.71 | — | COM | 78667J108 |
| IFRX | INFLARX NV | 2,876,080 | $60,254 | 5.0% | $17.97 | 0.0% | COM | N44821101 |
| — | BIOHAVEN PHARMACTL HLDG CO LTD | 1,997,278 | $53,887 | 4.5% | $25.00 | — | COM | G11196105 |
| — | ZOGENIX INC | 1,145,268 | $45,868 | 3.8% | $16.89 | — | COM NEW | 98978L204 |
| — | DICERNA PHARMACEUTICALS INC | 4,965,513 | $44,839 | 3.8% | $18.43 | — | COM | 253031108 |
| — | KALA PHARMACEUTICALS INC | 2,113,236 | $39,074 | 3.3% | $22.84 | — | COM | 483119103 |
| — | MYOVANT SCIENCES LTD | 2,830,455 | $35,777 | 3.0% | $12.11 | — | COM | G637AM102 |
| — | SCPHARMACEUTICALS INC | 2,857,143 | $34,543 | 2.9% | $12.09 | — | COM | 810648105 |
| BCRX | BIOCRYST PHARMACEUTICALS | 6,984,692 | $34,295 | 2.9% | $7.39 | -34.5% | COM | 09058V103 |
| — | KADMON HLDGS INC | 6,269,342 | $22,695 | 1.9% | $3.35 | — | COM | 48283N106 |
| APLS | APELLIS PHARMACEUTICALS INC | 900,000 | $19,530 | 1.6% | $14.72 | 0.0% | COM | 03753U106 |
| — | ENDOCYTE INC | 3,364,648 | $14,401 | 1.2% | $4.28 | — | COM | 29269A102 |
| SPRO | SPERO THERAPEUTICS INC | 1,225,647 | $14,401 | 1.2% | $12.27 | 0.0% | COM | 84833T103 |
| — | AVEO PHARMACEUTICALS INC | 5,062,759 | $14,125 | 1.2% | $2.59 | — | COM | 053588109 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,441,070 | $14,050 | 1.2% | $9.16 | +13.6% | COM | 483497103 |
| — | RA PHARMACEUTICALS INC | 1,351,808 | $11,490 | 1.0% | $15.19 | — | COM | 74933V108 |
| — | SUNESIS PHARMACEUTICALS INC | 3,096,840 | $11,427 | 1.0% | $3.69 | — | COM PAR | 867328700 |
| — | CLEMENTIA PHARMACEUTICALS INC COM NPV | 585,403 | $11,111 | 0.9% | $16.89 | — | COM | 185575107 |
| KRYS | KRYSTAL BIOTECH INC | 700,000 | $7,364 | 0.6% | $10.08 | -0.6% | COM | 501147102 |
| ARGX | ARGENX SE | 75,816 | $4,787 | 0.4% | $63.14 | — | SPONSORED ADR | 04016X101 |
| — | G1 THERAPEUTICS INC | 159,780 | $3,170 | 0.3% | $17.44 | — | COM | 3621LQ109 |
| — | PROTEON THERAPEUTICS INC | 1,337,462 | $2,541 | 0.2% | $1.53 | — | COM | 74371L109 |
| — | CHIASMA INC | 1,176,806 | $2,001 | 0.2% | $2.55 | — | COM | 16706W102 |
| — | ACHILLION PHARMACEUTICALS INC | 585,890 | $1,687 | 0.1% | $6.18 | — | COM | 00448Q201 |